Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Noradrenergic and Cholinergic Modulation of Belief Updating.

Jepma M, Brown SBRE, Murphy PR, Koelewijn SC, de Vries B, van den Maagdenberg AM, Nieuwenhuis S.

J Cogn Neurosci. 2018 Jul 31:1-18. doi: 10.1162/jocn_a_01317. [Epub ahead of print]

PMID:
30063180
2.

Coupling of respiration and attention via the locus coeruleus: Effects of meditation and pranayama.

Melnychuk MC, Dockree PM, O'Connell RG, Murphy PR, Balsters JH, Robertson IH.

Psychophysiology. 2018 Sep;55(9):e13091. doi: 10.1111/psyp.13091. Epub 2018 Apr 22.

PMID:
29682753
3.

U-turns in the brain.

O'Connell RG, Murphy PR.

Nat Neurosci. 2018 Apr;21(4):461-462. doi: 10.1038/s41593-018-0122-4. No abstract available.

PMID:
29593316
4.

Parsing the neural signatures of reduced error detection in older age.

Harty S, Murphy PR, Robertson IH, O'Connell RG.

Neuroimage. 2017 Nov 1;161:43-55. doi: 10.1016/j.neuroimage.2017.08.032. Epub 2017 Aug 12.

PMID:
28811254
5.

Erratum: Global gain modulation generates time-dependent urgency during perceptual choice in humans.

Murphy PR, Boonstra E, Nieuwenhuis S.

Nat Commun. 2017 Jan 18;8:14299. doi: 10.1038/ncomms14299. No abstract available.

6.

Global gain modulation generates time-dependent urgency during perceptual choice in humans.

Murphy PR, Boonstra E, Nieuwenhuis S.

Nat Commun. 2016 Nov 24;7:13526. doi: 10.1038/ncomms13526.

7.

Catecholaminergic Regulation of Learning Rate in a Dynamic Environment.

Jepma M, Murphy PR, Nassar MR, Rangel-Gomez M, Meeter M, Nieuwenhuis S.

PLoS Comput Biol. 2016 Oct 28;12(10):e1005171. doi: 10.1371/journal.pcbi.1005171. eCollection 2016 Oct.

8.

Pupil Diameter Tracks Lapses of Attention.

van den Brink RL, Murphy PR, Nieuwenhuis S.

PLoS One. 2016 Oct 21;11(10):e0165274. doi: 10.1371/journal.pone.0165274. eCollection 2016.

9.

Catecholaminergic Neuromodulation Shapes Intrinsic MRI Functional Connectivity in the Human Brain.

van den Brink RL, Pfeffer T, Warren CM, Murphy PR, Tona KD, van der Wee NJ, Giltay E, van Noorden MS, Rombouts SA, Donner TH, Nieuwenhuis S.

J Neurosci. 2016 Jul 27;36(30):7865-76. doi: 10.1523/JNEUROSCI.0744-16.2016.

10.

Commentary: Sensory integration dynamics in a hierarchical network explains choice probabilities in cortical area MT.

Urai AE, Murphy PR.

Front Syst Neurosci. 2016 May 3;10:37. doi: 10.3389/fnsys.2016.00037. eCollection 2016. No abstract available.

11.

The accessory stimulus effect is mediated by phasic arousal: A pupillometry study.

Tona KD, Murphy PR, Brown SB, Nieuwenhuis S.

Psychophysiology. 2016 Jul;53(7):1108-13. doi: 10.1111/psyp.12653. Epub 2016 Apr 20.

PMID:
27095087
12.

The Pupillary Orienting Response Predicts Adaptive Behavioral Adjustment after Errors.

Murphy PR, van Moort ML, Nieuwenhuis S.

PLoS One. 2016 Mar 24;11(3):e0151763. doi: 10.1371/journal.pone.0151763. eCollection 2016.

13.

Cognitive control, dynamic salience, and the imperative toward computational accounts of neuromodulatory function.

Warren CM, Murphy PR, Nieuwenhuis S.

Behav Brain Sci. 2016 Jan;39:e227. doi: 10.1017/S0140525X15001983.

PMID:
28347364
14.

Neural evidence accumulation persists after choice to inform metacognitive judgments.

Murphy PR, Robertson IH, Harty S, O'Connell RG.

Elife. 2015 Dec 19;4. pii: e11946. doi: 10.7554/eLife.11946.

15.

The classic P300 encodes a build-to-threshold decision variable.

Twomey DM, Murphy PR, Kelly SP, O'Connell RG.

Eur J Neurosci. 2015 Jul;42(1):1636-43. doi: 10.1111/ejn.12936. Epub 2015 May 28.

PMID:
25925534
16.

Pupil-linked arousal determines variability in perceptual decision making.

Murphy PR, Vandekerckhove J, Nieuwenhuis S.

PLoS Comput Biol. 2014 Sep 18;10(9):e1003854. doi: 10.1371/journal.pcbi.1003854. eCollection 2014 Sep.

17.

Chromatin-remodeling factors mediate the balance of sense-antisense transcription at the FGF2 locus.

McEachern LA, Murphy PR.

Mol Endocrinol. 2014 Apr;28(4):477-89. doi: 10.1210/me.2013-1220. Epub 2014 Feb 19.

18.

Pupil diameter covaries with BOLD activity in human locus coeruleus.

Murphy PR, O'Connell RG, O'Sullivan M, Robertson IH, Balsters JH.

Hum Brain Mapp. 2014 Aug;35(8):4140-54. doi: 10.1002/hbm.22466. Epub 2014 Feb 7.

PMID:
24510607
19.

An electrophysiological signal that precisely tracks the emergence of error awareness.

Murphy PR, Robertson IH, Allen D, Hester R, O'Connell RG.

Front Hum Neurosci. 2012 Mar 28;6:65. doi: 10.3389/fnhum.2012.00065. eCollection 2012.

20.

Regulation of fibroblast growth factor-2 expression and cell cycle progression by an endogenous antisense RNA.

Baguma-Nibasheka M, Macfarlane LA, Murphy PR.

Genes (Basel). 2012 Aug 16;3(3):505-20. doi: 10.3390/genes3030505.

21.

Pupillometry and P3 index the locus coeruleus-noradrenergic arousal function in humans.

Murphy PR, Robertson IH, Balsters JH, O'connell RG.

Psychophysiology. 2011 Nov;48(11):1532-1543. doi: 10.1111/j.1469-8986.2011.01226.x. Epub 2011 Jul 18.

PMID:
21762458
22.

MicroRNA: Biogenesis, Function and Role in Cancer.

Macfarlane LA, Murphy PR.

Curr Genomics. 2010 Nov;11(7):537-61. doi: 10.2174/138920210793175895.

23.

Regulation of FGF-2 by an endogenous antisense RNA: effects on cell adhesion and cell-cycle progression.

MacFarlane LA, Murphy PR.

Mol Carcinog. 2010 Dec;49(12):1031-44. doi: 10.1002/mc.20686.

PMID:
20945415
24.

Regulation of fibroblast growth factor-2 by an endogenous antisense RNA and by argonaute-2.

MacFarlane LA, Gu Y, Casson AG, Murphy PR.

Mol Endocrinol. 2010 Apr;24(4):800-12. doi: 10.1210/me.2009-0367. Epub 2010 Mar 2.

25.

Alternative splicing and differential subcellular localization of the rat FGF antisense gene product.

Zhang SC, MacDonald KA, Baguma-Nibasheka M, Geldenhuys L, Casson AG, Murphy PR.

BMC Mol Biol. 2008 Jan 23;9:10. doi: 10.1186/1471-2199-9-10.

26.

Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancer.

Thomas LN, Douglas RC, Lazier CB, Gupta R, Norman RW, Murphy PR, Rittmaster RS, Too CK.

J Urol. 2008 Jan;179(1):147-51. Epub 2007 Nov 13.

PMID:
17997435
27.

Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinoma.

Zhang SC, Barclay C, Alexander LA, Geldenhuys L, Porter GA, Casson AG, Murphy PR.

J Mol Med (Berl). 2007 Nov;85(11):1215-28. Epub 2007 Jun 14.

PMID:
17569023
28.

Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.

Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR.

Mol Carcinog. 2007 Dec;46(12):971-80.

PMID:
17477358
29.

The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells.

Baguma-Nibasheka M, Li AW, Murphy PR.

Mol Cell Endocrinol. 2007 Mar 15;267(1-2):127-36. Epub 2007 Jan 21.

PMID:
17306451
30.

Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene.

Barclay C, Li AW, Geldenhuys L, Baguma-Nibasheka M, Porter GA, Veugelers PJ, Murphy PR, Casson AG.

Clin Cancer Res. 2005 Nov 1;11(21):7683-91.

31.

Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells.

Baguma-Nibasheka M, Li AW, Osman MS, Geldenhuys L, Casson AG, Too CK, Murphy PR.

Leuk Res. 2005 Apr;29(4):423-33. Epub 2004 Dec 30.

PMID:
15725477
32.
34.

Transcriptional regulation of the leptin gene promoter in rat GH3 pituitary and C6 glioma cells.

Li AW, Morash B, Hollenberg AN, Ur E, Wilkinson M, Murphy PR.

Mol Cell Endocrinol. 2001 May 15;176(1-2):57-65.

PMID:
11369443
35.

The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone production.

Asa SL, Ramyar L, Murphy PR, Li AW, Ezzat S.

Mol Endocrinol. 2001 Apr;15(4):589-99.

PMID:
11266510
36.
37.
38.
39.

L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells.

Dodd F, Limoges M, Boudreau RT, Rowden G, Murphy PR, Too CK.

J Cell Biochem. 2000 Apr;77(4):624-34.

PMID:
10771518
40.

The role of static and dynamic fusimotor activity during locomotion.

Murphy PR.

J Physiol. 2000 Feb 1;522 Pt 3:347. No abstract available.

41.

Leptin gene expression in the brain and pituitary gland.

Morash B, Li A, Murphy PR, Wilkinson M, Ur E.

Endocrinology. 1999 Dec;140(12):5995-8.

PMID:
10579368
42.

Rejection with heart failure after pediatric cardiac transplantation.

Flippin MJ, Balzer DT, Murphy PR, Ruble SE, Mendeloff EN, Huddleston CB, Canter CE.

Ann Thorac Surg. 1999 Jul;68(1):176-80.

PMID:
10421137
43.

Adaptive fusimotor reflex control in the decerebrate cat.

Murphy PR.

Brain Res. 1999 Mar 6;821(1):38-49.

PMID:
10064786
44.

Prolactin induces expression of FGF-2 and a novel FGF-responsive NonO/p54nrb-related mRNA in rat lymphoma cells.

Too CK, Knee R, Pinette AL, Li AW, Murphy PR.

Mol Cell Endocrinol. 1998 Feb;137(2):187-95.

PMID:
9605521
45.

FGF-2 antisense RNA encodes a nuclear protein with MutT-like antimutator activity.

Li AW, Too CK, Knee R, Wilkinson M, Murphy PR.

Mol Cell Endocrinol. 1997 Oct 20;133(2):177-82.

PMID:
9406864
46.

Reversal of fusimotor reflex responses during locomotion in the decerebrate cat.

Murphy PR, Hammond GR.

Exp Physiol. 1997 Sep;82(5):837-58.

47.

Regulation of gene expression by natural antisense RNA transcripts.

Knee R, Murphy PR.

Neurochem Int. 1997 Sep;31(3):379-92. Review.

PMID:
9246680
48.
49.

Decline in basic fibroblast growth factor (FGF-2) mRNA expression in female rat hypothalamus at puberty.

Smyth CE, Knee R, Wilkinson M, Murphy PR.

J Neuroendocrinol. 1997 Feb;9(2):151-9.

PMID:
9041369
50.

The basic fibroblast growth factor (FGF-2) antisense RNA (GFG) is translated into a MutT-related protein in vivo.

Li AW, Too CK, Murphy PR.

Biochem Biophys Res Commun. 1996 Jun 5;223(1):19-23.

PMID:
8660369

Supplemental Content

Loading ...
Support Center